Meiji Yasuda Life Insurance CO Biomarin Pharmaceutical Inc Transaction History
Meiji Yasuda Life Insurance CO
- $4.97 Billion
- Q2 2024
A detailed history of Meiji Yasuda Life Insurance CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Meiji Yasuda Life Insurance CO holds 10,942 shares of BMRN stock, worth $769,113. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,942
Previous 6,942
57.62%
Holding current value
$769,113
Previous $606,000
48.51%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.6 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.34 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.32 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$979 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$681 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...